Skip to main content
. 2009 Jun;4(6):1065–1072. doi: 10.2215/CJN.03910808

Figure 1.

Figure 1.

Kaplan-Meier survival analysis of time interval to dialysis in different groups of patients with nephrotic syndrome. (A) Comparison of heterozygous carriers versus non-NPHS1/NPHS2 and homozygous carriers of NPHS2 mutation. (B) Three different groups of heterozygous carriers were split according to the presence of p.P20L, p.R229Q, or other mutations.